Publication | Closed Access

Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

InflammationRheumatologyAnti-tumour ResponseRheumatoid DisorderAutoimmune DiseaseAllergyMedicineRheumatic DiseasesImmunologyTumor ImmunityCase SeriesAutoimmunityInflammatory Rheumatic DiseaseImmune FunctionImmune SystemImmunotherapyInflammatory DiseaseDeath-1 Antibodies